Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Using Concept Maps to compare obesity knowledge between policy makers and primary care researchers in Canada.

Sturgiss E, Luig T, Campbell-Scherer DL, Lewanczuk R, Green LA.

BMC Res Notes. 2019 Jan 14;12(1):23. doi: 10.1186/s13104-018-4042-x.

2.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
3.

The effect of provider affiliation with a primary care network on emergency department visits and hospital admissions.

McAlister FA, Bakal JA, Green L, Bahler B, Lewanczuk R.

CMAJ. 2018 Mar 12;190(10):E276-E284. doi: 10.1503/cmaj.170385.

4.

Patient navigators for people with chronic disease: A systematic review.

McBrien KA, Ivers N, Barnieh L, Bailey JJ, Lorenzetti DL, Nicholas D, Tonelli M, Hemmelgarn B, Lewanczuk R, Edwards A, Braun T, Manns B.

PLoS One. 2018 Feb 20;13(2):e0191980. doi: 10.1371/journal.pone.0191980. eCollection 2018. Review.

5.

Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program.

Kimball SM, Emery JCH, Lewanczuk RZ.

J Clin Transl Endocrinol. 2017 Nov 7;10:28-35. doi: 10.1016/j.jcte.2017.11.002. eCollection 2017 Dec.

6.

Multimorbidity, dementia and health care in older people:a population-based cohort study.

Tonelli M, Wiebe N, Straus S, Fortin M, Guthrie B, James MT, Klarenbach SW, Tam-Tham H, Lewanczuk R, Manns BJ, Quan H, Ronksley PE, Sargious P, Hemmelgarn B; Alberta Kidney Disease Network.

CMAJ Open. 2017 Aug 14;5(3):E623-E631. doi: 10.9778/cmajo.20170052.

7.

Comparison of Methods to Define High Use of Inpatient Services Using Population-Based Data.

Wick J, Hemmelgarn B, Manns B, Tonelli M, Quan H, Lewanczuk R, Ronksley P.

J Hosp Med. 2017 Aug;12(8):596-602. doi: 10.12788/jhm.2778.

PMID:
28786424
8.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
9.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Ronksley PE, Tonelli M, Manns BJ, Weaver RG, Thomas CM, MacRae JM, Ravani P, Quinn RR, James MT, Lewanczuk R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):304-314. doi: 10.2215/CJN.06280616. Epub 2017 Jan 24.

10.

Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Houle SK, Charrois TL, McAlister FA, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):345-351. Epub 2016 Oct 3.

11.

Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Ronksley PE, Hemmelgarn BR, Manns BJ, Wick J, James MT, Ravani P, Quinn RR, Scott-Douglas N, Lewanczuk R, Tonelli M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2022-2031. Epub 2016 Oct 6.

12.

The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.

McBrien KA, Manns BJ, Hemmelgarn BR, Weaver R, Edwards AL, Ivers N, Rabi D, Lewanczuk R, Braun T, Naugler C, Campbell D, Saad N, Tonelli M.

Diabet Med. 2016 Nov;33(11):1499-1507. doi: 10.1111/dme.13023. Epub 2015 Dec 6.

PMID:
26526088
13.

Development and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods study.

Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K, Jindal K, Lewanczuk RZ, Scott-Douglas N, Braun T, Straus SE, Naugler C, Elliott MJ, Jun M, Hemmelgarn BR.

BMC Med Inform Decis Mak. 2016 Aug 17;16:109. doi: 10.1186/s12911-016-0350-z.

14.

Hypertension in Canada: Past, Present, and Future.

Schiffrin EL, Campbell NR, Feldman RD, Kaczorowski J, Lewanczuk R, Padwal R, Tobe SW.

Ann Glob Health. 2016 Mar-Apr;82(2):288-99. doi: 10.1016/j.aogh.2016.02.006. Review.

15.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
16.

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.

Tonelli M, Wiebe N, Guthrie B, James MT, Quan H, Fortin M, Klarenbach SW, Sargious P, Straus S, Lewanczuk R, Ronksley PE, Manns BJ, Hemmelgarn BR.

Kidney Int. 2015 Oct;88(4):859-66. doi: 10.1038/ki.2015.228. Epub 2015 Jul 29.

PMID:
26221754
17.

Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).

Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Cooney D, McAlister FA; RxACTION Investigators*.

Circulation. 2015 Jul 14;132(2):93-100. doi: 10.1161/CIRCULATIONAHA.115.015464. Epub 2015 Jun 10.

PMID:
26063762
18.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
19.

Pharmacists on primary care teams: Effect on antihypertensive medication management in patients with type 2 diabetes.

Omran D, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Guirguis LM, Makowsky M, Simpson SH.

J Am Pharm Assoc (2003). 2015 May-Jun;55(3):265-8. doi: 10.1331/JAPhA.2015.14225.

PMID:
25909463
20.

Methods for identifying 30 chronic conditions: application to administrative data.

Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, Klarenbach SW, Lewanczuk R, Manns BJ, Ronksley P, Sargious P, Straus S, Quan H; Alberta Kidney Disease Network.

BMC Med Inform Decis Mak. 2015 Apr 17;15:31. doi: 10.1186/s12911-015-0155-5.

21.

Patient navigators for people with chronic disease: protocol for a systematic review and meta-analysis.

Kelly E, Ivers N, Zawi R, Barnieh L, Manns B, Lorenzetti DL, Nicholas D, Tonelli M, Hemmelgarn B, Lewanczuk R, Edwards A, Braun T, McBrien KA.

Syst Rev. 2015 Mar 14;4:28. doi: 10.1186/s13643-015-0019-1.

22.

Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.

Simpson SH, Lier DA, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA.

Diabet Med. 2015 Jul;32(7):899-906. doi: 10.1111/dme.12692. Epub 2015 Feb 2.

PMID:
25594919
23.

Vitamin D supplementation in multiple sclerosis: making a case for clarity.

Kimball S, Hanwell HE, Burton JM, Heaney RP, Holick MF, Hollis B, Lewanczuk R, Makhani N, Venkateswaran S.

J Neurol Sci. 2014 Dec 15;347(1-2):391-2. doi: 10.1016/j.jns.2014.10.003. Epub 2014 Oct 8. No abstract available.

PMID:
25456464
24.

Capacity and willingness of patients with chronic noncommunicable diseases to use information technology to help manage their condition: a cross-sectional study.

Afshar AE, Weaver RG, Lin M, Allan M, Ronksley PE, Sanmartin C, Lewanczuk R, Rosenberg M, Manns B, Hemmelgarn B, Tonelli M; Interdisciplinary Chronic Disease Collaboration.

CMAJ Open. 2014 Apr 16;2(2):E51-9. doi: 10.9778/cmajo.20130070. eCollection 2014 Apr.

25.

Access to primary care and other health care use among western Canadians with chronic conditions: a population-based survey.

Weaver RG, Manns BJ, Tonelli M, Sanmartin C, Campbell DJ, Ronksley PE, Lewanczuk R, Braun TC, Hennessy D, Hemmelgarn BR.

CMAJ Open. 2014 Mar 7;2(1):E27-34. doi: 10.9778/cmajo.20130045. eCollection 2014 Jan.

26.

Outdoor time is associated with physical activity, sedentary time, and cardiorespiratory fitness in youth.

Schaefer L, Plotnikoff RC, Majumdar SR, Mollard R, Woo M, Sadman R, Rinaldi RL, Boulé N, Torrance B, Ball GD, Veugelers P, Wozny P, McCargar L, Downs S, Lewanczuk R, Gleddie D, McGavock J.

J Pediatr. 2014 Sep;165(3):516-21. doi: 10.1016/j.jpeds.2014.05.029. Epub 2014 Jul 17.

PMID:
25043155
27.

Vascular protection in people with diabetes.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Stone JA, Fitchett D, Grover S, Lewanczuk R, Lin P.

Can J Diabetes. 2013 Apr;37 Suppl 1:S100-4. doi: 10.1016/j.jcjd.2013.01.030. Epub 2013 Mar 26. No abstract available.

PMID:
24070927
28.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

29.

Exercise training improves aerobic capacity, muscle strength, and quality of life in renal transplant recipients.

Riess KJ, Haykowsky M, Lawrance R, Tomczak CR, Welsh R, Lewanczuk R, Tymchak W, Haennel RG, Gourishankar S.

Appl Physiol Nutr Metab. 2014 May;39(5):566-71. doi: 10.1139/apnm-2013-0449. Epub 2013 Nov 28.

PMID:
24766239
30.

Pharmacist intervention for glycaemic control in the community (the RxING study).

Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki RT.

BMJ Open. 2013 Sep 24;3(9):e003154. doi: 10.1136/bmjopen-2013-003154. Erratum in: BMJ Open. 2013;3(10):e003154corr1.

31.

A case of acute respiratory distress syndrome responsive to methylene blue during a carcinoid crisis.

van Diepen S, Sobey A, Lewanczuk R, Singh G, Sidhu S, Zibdawi M, Mullen JC.

Can J Anaesth. 2013 Nov;60(11):1085-8. doi: 10.1007/s12630-013-0026-4. Epub 2013 Sep 14.

PMID:
24037749
32.

Vigorous physical activity and longitudinal associations with cardiometabolic risk factors in youth.

Carson V, Rinaldi RL, Torrance B, Maximova K, Ball GD, Majumdar SR, Plotnikoff RC, Veugelers P, Boulé NG, Wozny P, McCargar L, Downs S, Daymont C, Lewanczuk R, McGavock J.

Int J Obes (Lond). 2014 Jan;38(1):16-21. doi: 10.1038/ijo.2013.135. Epub 2013 Jul 26.

PMID:
23887061
33.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
34.

Anthropometric and dietary predictors of insulin sensitivity in 10- to 14-year-old boys and girls.

Forbes LE, Downs SM, Fraser SN, Majumdar SR, Ball GD, Plotnikoff RC, Wozny PD, Torrance BD, McCargar LJ, Lewanczuk RZ, McGavock JM.

Appl Physiol Nutr Metab. 2013 Mar;38(3):320-5. doi: 10.1139/apnm-2012-0232. Epub 2012 Oct 12.

PMID:
23537025
35.

Treating patients and treating populations: the value of population data in controlling hypertension.

Lewanczuk RZ.

Can J Cardiol. 2013 May;29(5):524-5. doi: 10.1016/j.cjca.2013.02.002. Epub 2013 Mar 21. No abstract available.

PMID:
23523106
36.

Use of chronic disease management programs for diabetes: in Alberta's primary care networks.

Campbell DJ, Sargious P, Lewanczuk R, McBrien K, Tonelli M, Hemmelgarn B, Manns B.

Can Fam Physician. 2013 Feb;59(2):e86-92.

37.

Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.

Gilani F, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, Simpson SH.

Ann Pharmacother. 2013 Jan;47(1):43-8. doi: 10.1345/aph.1R552. Epub 2013 Jan 16.

PMID:
23324512
38.

Physical activity intensity and cardiometabolic risk in youth.

Hay J, Maximova K, Durksen A, Carson V, Rinaldi RL, Torrance B, Ball GD, Majumdar SR, Plotnikoff RC, Veugelers P, Boulé NG, Wozny P, McCargar L, Downs S, Lewanczuk R, McGavock J.

Arch Pediatr Adolesc Med. 2012 Nov;166(11):1022-9. doi: 10.1001/archpediatrics.2012.1028.

PMID:
22965682
39.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447
40.

Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.

Ladhani NN, Majumdar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, Simpson SH.

Diabet Med. 2012 Nov;29(11):1433-9. doi: 10.1111/j.1464-5491.2012.03673.x.

PMID:
22486226
41.

A framework for discussion on how to improve prevention, management, and control of hypertension in Canada.

Campbell N, Young ER, Drouin D, Legowski B, Adams MA, Farrell J, Kaczorowski J, Lewanczuk R, Moy Lum-Kwong M, Tobe S.

Can J Cardiol. 2012 May;28(3):262-9. doi: 10.1016/j.cjca.2011.11.008. Epub 2012 Jan 30. Review.

PMID:
22284588
42.

Enrolment in primary care networks: impact on outcomes and processes of care for patients with diabetes.

Manns BJ, Tonelli M, Zhang J, Campbell DJ, Sargious P, Ayyalasomayajula B, Clement F, Johnson JA, Laupacis A, Lewanczuk R, McBrien K, Hemmelgarn BR.

CMAJ. 2012 Feb 7;184(2):E144-52. doi: 10.1503/cmaj.110755. Epub 2011 Dec 5.

43.

Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods.

Charrois TL, McAlister FA, Cooney D, Lewanczuk R, Kolber MR, Campbell NR, Rosenthal M, Houle SK, Tsuyuki RT.

Implement Sci. 2011 Aug 11;6:94. doi: 10.1186/1748-5908-6-94.

44.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2. doi: 10.1016/j.cjca.2011.03.015. English, French.

PMID:
21801975
45.

Metformin and exercise in type 2 diabetes: examining treatment modality interactions.

Boulé NG, Robert C, Bell GJ, Johnson ST, Bell RC, Lewanczuk RZ, Gabr RQ, Brocks DR.

Diabetes Care. 2011 Jul;34(7):1469-74. doi: 10.2337/dc10-2207. Epub 2011 May 20.

46.

Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Sanaee F, Clements JD, Waugh AW, Fedorak RN, Lewanczuk R, Jamali F.

Br J Clin Pharmacol. 2011 Nov;72(5):787-97. doi: 10.1111/j.1365-2125.2011.04019.x.

47.

Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):124-31. doi: 10.1016/j.cjca.2011.01.016. Review.

PMID:
21459258
48.

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.

Cardiometabolic Risk Working Group: Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K, Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R, Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R, Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.

Can J Cardiol. 2011 Mar-Apr;27(2):e1-e33. doi: 10.1016/j.cjca.2010.12.054. Review.

PMID:
21459257
49.

Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study.

Padwal RS, Damjanovic S, Schulze KM, Lewanczuk RZ, Lau DC, Sharma AM.

J Obes. 2011;2011:686521. doi: 10.1155/2011/686521. Epub 2010 Nov 21.

50.

Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.

Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA.

Diabetes Care. 2011 Jan;34(1):20-6. doi: 10.2337/dc10-1294. Epub 2010 Oct 7.

Supplemental Content

Loading ...
Support Center